Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Katz

Showing results (111-120 of 185) with videos related to

Pageof 19
Sort By:
American Journal of Ophthalmology|October 15, 2021
Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial"Thomas W Samuelson, Inder Paul Singh, Blake K Williamson, et al.
Eye (London, England)|May 23, 2023
Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trialAnastasios-Georgios Konstas, Konstadinos G Boboridis, Georgios P Athanasopoulos, et al.
Ophthalmology and Therapy|October 4, 2025
Administration of the Travoprost Intracameral Implant in an Office-Based Surgery SettingInder Paul Singh, George R Reiss, Brian E Flowers, et al.
Ophthalmology and Therapy|March 15, 2026
Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular HypertensionJohn P Berdahl, Robert P Lehmann, Jason J Jones, et al.
The British Journal of Ophthalmology|June 29, 2017
Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment ProjectLaura T Pizzi, Michael Waisbourd, Lisa Hark, et al.
American Journal of Ophthalmology|December 5, 2017
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)Janet B Serle, L Jay Katz, Eugene McLaurin, et al.
Journal of Glaucoma|August 3, 2020
Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for GlaucomaLucas Bonafede, Carina T Sanvicente, Lisa A Hark, et al.
Molecular Vision|May 10, 2011
Down-regulation of OPA1 in patients with primary open angle glaucomaThomas M Bosley, Ali Hellani, George L Spaeth, et al.
Transactions of the American Ophthalmological Society|January 28, 2003
The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucomaGeorge L Spaeth, Jeffrey Henderer, Connie Liu, et al.
Evaluation and Program Planning|July 10, 2017
Applying RE-AIM to evaluate two community-based programs designed to improve access to eye care for those at high-risk for glaucomaSaloni Sapru, Jennifer Berktold, John E Crews, et al.
Pageof 19

Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
American Journal of Ophthalmology|October 15, 2021
Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial"Thomas W Samuelson, Inder Paul Singh, Blake K Williamson, et al.
Eye (London, England)|May 23, 2023
Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trialAnastasios-Georgios Konstas, Konstadinos G Boboridis, Georgios P Athanasopoulos, et al.
Ophthalmology and Therapy|October 4, 2025
Administration of the Travoprost Intracameral Implant in an Office-Based Surgery SettingInder Paul Singh, George R Reiss, Brian E Flowers, et al.
Ophthalmology and Therapy|March 15, 2026
Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular HypertensionJohn P Berdahl, Robert P Lehmann, Jason J Jones, et al.
The British Journal of Ophthalmology|June 29, 2017
Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment ProjectLaura T Pizzi, Michael Waisbourd, Lisa Hark, et al.
American Journal of Ophthalmology|December 5, 2017
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)Janet B Serle, L Jay Katz, Eugene McLaurin, et al.
Journal of Glaucoma|August 3, 2020
Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for GlaucomaLucas Bonafede, Carina T Sanvicente, Lisa A Hark, et al.
Molecular Vision|May 10, 2011
Down-regulation of OPA1 in patients with primary open angle glaucomaThomas M Bosley, Ali Hellani, George L Spaeth, et al.
Transactions of the American Ophthalmological Society|January 28, 2003
The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucomaGeorge L Spaeth, Jeffrey Henderer, Connie Liu, et al.
Evaluation and Program Planning|July 10, 2017
Applying RE-AIM to evaluate two community-based programs designed to improve access to eye care for those at high-risk for glaucomaSaloni Sapru, Jennifer Berktold, John E Crews, et al.
Pageof 19